London - An experimental coronavirus vaccine being developed by AstraZeneca and Oxford university was safe and produced an immune response in early-stage clinical trials, data showed on Monday, keeping alive the hope it could be in use by the end of the year. The vaccine, called AZD1222, has been described by the World Health Organization's chief scientist as the leading candidate in a global race to halt a pandemic that has...
Full ArticleFirst human trial of Oxford Covid-19 vaccine shows promise
WorldNews
0 shares
3 views
You might like
Related news coverage
Early data from AstraZeneca and Oxford's coronavirus vaccine shows an immune response
Business Insider
Hello,
Today, we're tuning in to see drugmakers testify before Congress. But in the meantime, here's what's happening in..
-
India readies five sites for final phase of human trials of Oxford COVID vaccine
Mid-Day
-
Indian Govt Will Distribute COVID-19 Vaccine For Free: Adar Poonawalla
Fossbytes
-
Early stage human trial data shows Oxford COVID-19 vaccine provides antibodies and killer T cells
CBS News
-
Support grows for deliberately exposing vaccine trial subjects to COVID-19, with Oxford team leading the way
National Post
Advertisement
More coverage
AstraZeneca shares slide even as the company's coronavirus vaccine trial results show 'promise'
Business Insider
· *AstraZeneca shares slid on Monday despite positive news from the drugmaker's first human COVID-19 vaccine trials.*
· *The..
-
UK coronavirus vaccine shows early promise
Al Jazeera
-
Oxford coronavirus vaccine triggers strong immune response, trial shows
Brisbane Times
-
First human trial of Oxford coronavirus vaccine shows promise
Al Jazeera
-
NA Proactive news snapshot: Ipsidy, Avalon GloboCare, BioSig Technologies, Co-Diagnostics, Black Iron, Thunderbird Entertainment UPDATE …
Proactive Investors